Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 10,480 shares at $301.42 ($3.2M) on 2022-08-09, disclosed to the SEC on 2022-08-10.
Seasonal sale ($3.2M) by EVP, COO — this insider has traded VRTX in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $300.53 | 4,790 | $1.4M | 45.7% |
| 2 | $300.53 | 4,790 | $1.4M | 45.7% |
| 3 | $301.42 | 900 | $271K | 8.6% |
| Total | $300.61 avg | 10,480 | $3.2M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |